Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Comment by AREQUIPAon May 16, 2019 4:32pm
107 Views
Post# 29753007

RE:GREAT INTERVIEW ON CNBC

RE:GREAT INTERVIEW ON CNBCRegardless if you liked the interview or not, that aired on CNBC. IMHO, I thought it was very well stated that ACB is one of the front runners and deserves a close look. Very positive comments. The patient and long investors here realize how big that exposure was to the Investing audience. If you were waiting for a jump start, that may very well have been it. I will admit that I have traded this stock and made money buying low and selling high, but no more. After that interview, I'm not risking getting left behind. I think it's time to settle in. I don't think a deal with multiple partners for future products is a matter of if, but when. It sure sounds like the new high profile man at the helm is working hard to put it all together. It all might take just a little more time, but the cautious, non reckless direction sounds good to me. Thanks for posting the link.
Bullboard Posts